Immune-Mediated Liver Effects Associated With Administration of a Human Anti-IL-21 Receptor Antibody (ATR-107) in Rats.
Saved in:
| Title: | Immune-Mediated Liver Effects Associated With Administration of a Human Anti-IL-21 Receptor Antibody (ATR-107) in Rats. |
|---|---|
| Authors: | Hu W; Pfizer Inc., San Diego, California, USA.; Vividion Therapeutics, San Diego, California, USA., Buetow BS; Pfizer Inc., San Diego, California, USA., Sachdeva K; Wyeth, Chazy, New York, USA., Leach MW; Pfizer Inc., Cambridge, Massachusetts, USA.; Trident Toxicology, Inc., Shrewsbury, Massachusetts, USA. |
| Source: | Toxicologic pathology [Toxicol Pathol] 2024 Jul; Vol. 52 (5), pp. 232-250. Date of Electronic Publication: 2024 Jul 25. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
